Log In
BCIQ
Print this Print this
 

Lymphocyte-activation gene 3 (LAG3) (CD223)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Lymphocyte-activation gene 3 (LAG3) (CD223)

BCIQ
Print ChartPrint this
1 0 0 1 1 1 0 1 0
Phases of DevelopmentPreclinicalPhase IPhase I/II
Autoimmune

0

1

0

Cancer

1

1

1

Transplant

1

0

0




 Products Targeting Lymphocyte-activation gene 3 (LAG3) (CD223)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$488.1M

$52.8M

$496.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today